复发性原发性肝脂肪瘤手术切除加局部局部治疗。

IF 2.4 Q3 MEDICINE, RESEARCH & EXPERIMENTAL
Wafa Dahmani, Sahar Nasr, Kais Maalel, Yasser Becheikh, Ahmed Tibaoui, Zainab Lajmi, Sihem Hmissa, Hanene Jaziri, Nour Elleuch, Aida Ben Slama, Wafa Ben Ameur, Mahdi Ksiaa, Ali Jmaa
{"title":"复发性原发性肝脂肪瘤手术切除加局部局部治疗。","authors":"Wafa Dahmani,&nbsp;Sahar Nasr,&nbsp;Kais Maalel,&nbsp;Yasser Becheikh,&nbsp;Ahmed Tibaoui,&nbsp;Zainab Lajmi,&nbsp;Sihem Hmissa,&nbsp;Hanene Jaziri,&nbsp;Nour Elleuch,&nbsp;Aida Ben Slama,&nbsp;Wafa Ben Ameur,&nbsp;Mahdi Ksiaa,&nbsp;Ali Jmaa","doi":"10.2144/fsoa-2022-0046","DOIUrl":null,"url":null,"abstract":"<p><p>Vasoactive intestinal peptide (VIP) secreting tumors (VIPomas) are insidious functional neuroendocrine tumors originating mainly from pancreatic islet cells. Hepatic localization is considered exceedingly rare as only few cases have been reported in the literature. Diagnostic and therapeutic management of this tumor is still not clearly codified and therefore represents a real challenge for clinicians. Herein we report a unique case of a primary hepatic VIPoma recurrence in a female patient 22 years after curative resection. The patient had two sessions of transarterial chemoembolization. Complete symptomatic improvement was achieved since the first day after the first session. This case highlights that long-term follow-up for patients with hepatic VIPoma is mandatory as recurrence could occur several years after curative surgical treatment.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"9 1","pages":"FSO836"},"PeriodicalIF":2.4000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051143/pdf/","citationCount":"0","resultStr":"{\"title\":\"Recurrent primary hepatic VIPoma treated with a combination of surgical resection and loco-regional therapy.\",\"authors\":\"Wafa Dahmani,&nbsp;Sahar Nasr,&nbsp;Kais Maalel,&nbsp;Yasser Becheikh,&nbsp;Ahmed Tibaoui,&nbsp;Zainab Lajmi,&nbsp;Sihem Hmissa,&nbsp;Hanene Jaziri,&nbsp;Nour Elleuch,&nbsp;Aida Ben Slama,&nbsp;Wafa Ben Ameur,&nbsp;Mahdi Ksiaa,&nbsp;Ali Jmaa\",\"doi\":\"10.2144/fsoa-2022-0046\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Vasoactive intestinal peptide (VIP) secreting tumors (VIPomas) are insidious functional neuroendocrine tumors originating mainly from pancreatic islet cells. Hepatic localization is considered exceedingly rare as only few cases have been reported in the literature. Diagnostic and therapeutic management of this tumor is still not clearly codified and therefore represents a real challenge for clinicians. Herein we report a unique case of a primary hepatic VIPoma recurrence in a female patient 22 years after curative resection. The patient had two sessions of transarterial chemoembolization. Complete symptomatic improvement was achieved since the first day after the first session. This case highlights that long-term follow-up for patients with hepatic VIPoma is mandatory as recurrence could occur several years after curative surgical treatment.</p>\",\"PeriodicalId\":12568,\"journal\":{\"name\":\"Future Science OA\",\"volume\":\"9 1\",\"pages\":\"FSO836\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051143/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Future Science OA\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2144/fsoa-2022-0046\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future Science OA","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2144/fsoa-2022-0046","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

摘要

血管活性肠肽(VIP)分泌瘤(VIPomas)是一种主要起源于胰岛细胞的隐匿性功能性神经内分泌肿瘤。肝定位被认为是极其罕见的,只有少数病例报道在文献中。这种肿瘤的诊断和治疗管理仍然没有明确的法规,因此对临床医生来说是一个真正的挑战。在此,我们报告一个独特的情况下,原发性肝VIPoma复发的女性患者22年后治愈性切除。患者接受了两次经动脉化疗栓塞。自第一次治疗后的第一天起,症状完全改善。这个病例强调了对肝腺瘤患者的长期随访是必要的,因为在根治性手术治疗几年后可能会复发。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Recurrent primary hepatic VIPoma treated with a combination of surgical resection and loco-regional therapy.

Recurrent primary hepatic VIPoma treated with a combination of surgical resection and loco-regional therapy.

Recurrent primary hepatic VIPoma treated with a combination of surgical resection and loco-regional therapy.

Recurrent primary hepatic VIPoma treated with a combination of surgical resection and loco-regional therapy.

Vasoactive intestinal peptide (VIP) secreting tumors (VIPomas) are insidious functional neuroendocrine tumors originating mainly from pancreatic islet cells. Hepatic localization is considered exceedingly rare as only few cases have been reported in the literature. Diagnostic and therapeutic management of this tumor is still not clearly codified and therefore represents a real challenge for clinicians. Herein we report a unique case of a primary hepatic VIPoma recurrence in a female patient 22 years after curative resection. The patient had two sessions of transarterial chemoembolization. Complete symptomatic improvement was achieved since the first day after the first session. This case highlights that long-term follow-up for patients with hepatic VIPoma is mandatory as recurrence could occur several years after curative surgical treatment.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Future Science OA
Future Science OA MEDICINE, RESEARCH & EXPERIMENTAL-
CiteScore
5.00
自引率
4.00%
发文量
48
审稿时长
13 weeks
期刊介绍: Future Science OA is an online, open access, peer-reviewed title from the Future Science Group. The journal covers research and discussion related to advances in biotechnology, medicine and health. The journal embraces the importance of publishing all good-quality research with the potential to further the progress of research in these fields. All original research articles will be considered that are within the journal''s scope, and have been conducted with scientific rigour and research integrity. The journal also features review articles, editorials and perspectives, providing readers with a leading source of commentary and analysis. Submissions of the following article types will be considered: -Research articles -Preliminary communications -Short communications -Methodologies -Trial design articles -Trial results (including early-phase and negative studies) -Reviews -Perspectives -Commentaries
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信